Internal Medicine, Endocrinology, Diabetes, & Metabolism · Harwich, MA
NPI
1700854619
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
525 Long Pond Dr, Fontaine Medical Center
Harwich, MA, 02645
Phone (508) 432-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
1,806 services
Medicare patients, 2024
1,021
Average age 75
Drug cost, 2024
$2.8M
9,577 prescriptions
Company payments, 2025
$490
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ziad G Farah was code 99214 (office e&m - established), 642 times for 560 patients. In total Ziad G Farah billed 1,806 services in 14 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 642 | 560 | $90.73 | $58K |
| 99213 Office E&M - Established | Office | 367 | 354 | $64.34 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 211 | 211 | $12.90 | $2,723 |
| 83036 Blood Count | Office | 163 | 155 | $9.40 | $1,533 |
| 99204 Office E&M - New | Office | 97 | 97 | $125.56 | $12K |
| 99203 Office E&M - New | Office | 25 | 25 | $75.07 | $1,877 |
| 99451 E&M - Miscellaneous | Office | 19 | 19 | $25.56 | $486 |
| 99441 Telephone Services | Office | 15 | 12 | $26.05 | $391 |
By year: 2022 $165K for 2,166 services; 2023 $146K for 2,310 services; 2024 $107K for 1,806 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 163 | 155 | $9.40 | $1,533 |
Medicare prescription drug claims, 2024
In 2024, the drug Ziad G Farah prescribed most often to Medicare patients was Levothyroxine Sodium, with 948 prescriptions and refills. In total Ziad G Farah wrote 9,577 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 948 | 2,538 | 285 | $11K |
| Ozempic Semaglutide | 522 | 658 | 105 | $609K |
| Metformin Hcl Generic | 509 | 1,348 | 153 | $5,298 |
| Jardiance Empagliflozin | 414 | 731 | 100 | $417K |
| Glipizide Er Glipizide | 407 | 1,117 | 138 | $9,622 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 372 | 823 | 117 | $78K |
| Metformin Hcl Er Metformin Hcl | 338 | 959 | 113 | $5,265 |
| Glimepiride Generic | 313 | 861 | 98 | $4,677 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 268 | 633 | 93 | $24K |
| Januvia Sitagliptin Phosphate | 223 | 471 | 54 | $246K |
| Trulicity Dulaglutide | 194 | 266 | 47 | $252K |
| Alendronate Sodium Generic | 177 | 471 | 65 | $1,578 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 176 | 330 | 66 | $18K |
| Rosuvastatin Calcium Generic | 175 | 453 | 58 | $5,898 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 173 | 369 | 58 | $124K |
Brand drugs: 3,539 claims; generic drugs: 5,330 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ziad G Farah $490 ($490 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbott Laboratories with $188.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $188 |
| Soleno Therapeutics, Inc. SLNO | 2 | $48.54 |
| Amgen Inc. AMGN | 2 | $43.61 |
| Xeris Pharmaceuticals, Inc. | 2 | $34.79 |
| Novo Nordisk Inc NVO | 2 | $33.8 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $33.1 |
| Antares Pharma, Inc. | 1 | $26.71 |
| Dexcom, Inc. DXCM | 1 | $21.11 |
| Lilly USA, LLC LLY | 1 | $18.92 |
| RGH Enterprises LLC | 1 | $16.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.